Clariterm Injection is a sterile formulation containing 500 mg of clarithromycin, a potent macrolide antibiotic. It is designed for intravenous administration and is effective against a wide range of bacterial infections. Clarithromycin works by inhibiting bacterial protein synthesis, thereby stopping the growth of susceptible bacteria. This makes it an essential option in the treatment of various infections, including respiratory tract infections, skin infections, and certain types of stomach ulcers caused by Helicobacter pylori.
The rapid onset of action and broad-spectrum activity of Clariterm makes it particularly valuable in hospital settings, where it can be used to treat serious infections in patients unable to take oral medications. Its formulation is designed for easy reconstitution, ensuring that healthcare professionals can prepare it efficiently for patient use.
Clariterm Injection is generally well-tolerated, but like all medications, it may cause side effects. Commonly reported side effects include gastrointestinal disturbances such as nausea, vomiting, and diarrhea. Less frequently, patients may experience allergic reactions or effects on liver function, which should be monitored.